Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Patrizia, Falco"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 17, p 9142 (2024)
Iron is a vital element involved in a plethora of metabolic activities. Mammalian systemic iron homeostasis is mainly modulated by hepcidin, the synthesis of which is regulated by a number of proteins, including the hemochromatosis-associated protein
Externí odkaz:
https://doaj.org/article/1fb21eeb005f418c81db614abe2a6c9a
Autor:
Sara Bringhen, Mattia D’Agostino, Laura Paris, Stelvio Ballanti, Norbert Pescosta, Stefano Spada, Sara Pezzatti, Mariella Grasso, Delia Rota-Scalabrini, Luca De Rosa, Vincenzo Pavone, Giulia Gazzera, Sara Aquino, Marco Poggiu, Armando Santoro, Massimo Gentile, Luca Baldini, Maria Teresa Petrucci, Patrizia Tosi, Roberto Marasca, Claudia Cellini, Antonio Palumbo, Patrizia Falco, Roman Hájek, Mario Boccadoro, Alessandra Larocca
Publikováno v:
Haematologica, Vol 105, Iss 7 (2020)
n the EMN01 trial, the addition of an alkylator (melphalan or cyclophosphamide) to lenalidomide-steroid induction therapy was prospectively evaluated in transplant-ineligible patients with multiple myeloma. After induction, patients were randomly ass
Externí odkaz:
https://doaj.org/article/9b964beaa1304beda086763a5297de0d
Autor:
Stefano Fiori, Elisabetta Todisco, Safaa Ramadan, Federica Gigli, Patrizia Falco, Alessandra Iurlo, Cristiano Rampinelli, Giorgio Croci, Stefano A. Pileri, Corrado Tarella
Publikováno v:
Biology, Vol 10, Iss 2, p 152 (2021)
Tyrosine kinase inhibitors (TKIs) are the treatment of choice for BCR-ABL1-positive chronic myeloid leukemia (CML). Although TKIs have substantially improved prognosis of CML patients, their use is not free of adverse effects. Dasatinib is a second g
Externí odkaz:
https://doaj.org/article/9ec56097edfc4b2090c83cebb315c23c
Autor:
Andrea Piolatto, Gennaro Boccia, Alessandra Manca, Carmen Gaglioti, Teresa Ceglie, Caterina Cosentino, Luca Beratto, Jessica Cusato, Patrizia Falco, Silvia De Carlo, Filomena Longo, Antonella Roetto, Antonio Piga, Antonio D'Avolio, Alberto Rainoldi, Giovanni Battista Ferrero
Publikováno v:
Blood. 140:8208-8209
Autor:
Antonio Palumbo, Patrizia Falco
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 30, Pp 10-17 (2008)
The advances in the understanding of the pathogenesis of multiple myeloma and the mechanism of drug resistance have led to the development of novel targeted therapies that are able to overcome resistance and show additive or synergistic effects with
Externí odkaz:
https://doaj.org/article/3e81d3bd6c184a9bb7989e0951bd5cc7
Autor:
Mariarosa Mezzanotte, Dilay Yilmaz, Patrizia Falco, Alice Barinotti, Daniele Mancardi, Antonella Roetto
Publikováno v:
Vascular Pharmacology. 146:107059
Autor:
Cristiano Rampinelli, Elisabetta Todisco, Patrizia Falco, Alessandra Iurlo, Stefano Fiori, Federica Gigli, Corrado Tarella, Giorgio Alberto Croci, Stefano Pileri, Safaa M. Ramadan
Publikováno v:
Biology, Vol 10, Iss 152, p 152 (2021)
Biology
Biology
Simple Summary Tyrosine kinase inhibitors (TKIs) are the treatment of choice for BCR-ABL1-positive chronic myeloid leukemia (CML). Dasatinib is a second generation TKI frequently associated with pleural effusion in up to 33% of patients. Here, we des
Autor:
G. Gaidano, Andrea Ledda, R Zambello, Alessandra Larocca, A. Palumbo, N. Di Renzo, M.T. Petrucci, Stefano Spada, Roberto Marasca, Massimo Aglietta, Nicola Cascavilla, M. Boccadoro, Michele Cavo, L. De Rosa, S Bringhen, Marco Salvini, Alberto Bosi, Tommasina Guglielmelli, Annalisa Bernardini, Giulia Benevolo, L. Baldini, Patrizia Falco
Publikováno v:
HemaSphere. 3:244
Autor:
Paola Omedè, Filippo Marmont, Daniela Gioia, Dario Ferrero, Gianni Cametti, Giuliana Strola, Massimo Geuna, Maria Matilde Ciriello, M. Girotto, Berardino Pollio, Giuseppina Prato, Gianluca Gaidano, Marisa Pautasso, Giuseppe Saglio, Flavia Salvi, Margherita Bonferroni, Patrizia Falco, Alessandro Levis, Patrizia Notari, Roberto Freilone, Alessandra Stacchini, Carlo Marinone
Publikováno v:
European Journal of Haematology. 87:409-418
OBJECTIVES Morphology and cytogenetics are currently used to define prognosis in myelodysplastic syndromes (MDS). However, these parameters have some limits. Flow cytometry has been recently included in the diagnostic panel for MDS, and its prognosti
Autor:
Francesca Gay, S. Vincent Rajkumar, Patrizia Falco, Shaji Kumar, Angela Dispenzieri, Maria Teresa Petrucci, Morie A. Gertz, Mario Boccadoro, A. Keith Stewart, Antonio Palumbo
Publikováno v:
European Journal of Haematology. 85:200-208
Background: The goal of this retrospective study was to compare the efficacy and toxicity of lenalidomide–dexamethasone (len/dex) vs. melphalan–prednisone–lenalidomide (MPR) as upfront therapy for newly diagnosed elderly patients with myeloma.